More tools:Markets·Screener·Research·Chat

Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK) Financial Statements

Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG001T8N8N0
XNYS · usd
18.35▼ 0.10 (-0.54%)
As of 2026-09-08
Valuation
Market Cap
Enterprise Value
Trailing P/E—
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close18.45
Day's Range18.39 – 18.54
52-Week Range12.99 – 18.90
Volume1.5M
Avg Volume3.0M
Share Statistics
Shares Outstanding
Employees47.5K
ExchangeXNYS
Listed2008-03-07
Share count as of March 31, 2026
Loading Income Statement…
Key questions about Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
What is Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)'s Market Cap?
Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)'s Market Cap is $31.6B, based on as-reported figures from SEC (XBRL) filings.
What is Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)'s Enterprise Value?
Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)'s Enterprise Value is $52.5B, based on as-reported figures from SEC (XBRL) filings.
What is Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)'s Price / Sales?
Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)'s Price / Sales is 1.1×, based on as-reported figures from SEC (XBRL) filings.
What is Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)'s EV / Revenue?
Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)'s EV / Revenue is 1.9×, based on as-reported figures from SEC (XBRL) filings.
What is Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)'s EV / EBITDA?
Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)'s EV / EBITDA is 17.6×, based on as-reported figures from SEC (XBRL) filings.
What is Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)'s Revenue (TTM)?
Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)'s Revenue (TTM) is $28.3B, based on as-reported figures from SEC (XBRL) filings.
What is Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)'s Net Income (TTM)?
Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)'s Net Income (TTM) is -$956.3M, based on as-reported figures from SEC (XBRL) filings.
What is Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)'s EBITDA?
Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)'s EBITDA is $4.6B, based on as-reported figures from SEC (XBRL) filings.
What is Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)'s Diluted EPS (TTM)?
Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)'s Diluted EPS (TTM) is -0.55, based on as-reported figures from SEC (XBRL) filings.
What is Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)'s EBITDA Margin?
Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)'s EBITDA Margin is 16.1%, based on as-reported figures from SEC (XBRL) filings.
No Quarterly data available for this company — showing Annual instead. This company files annual reports only — foreign private issuers (Form 20-F / 40-F) are not required to file quarterly reports, so no quarterly figures exist to show.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in millions of USD, except per-share data)
Source: Akyla.ai
Line ItemMar 31, 2026Mar 31, 2025Mar 31, 2024Mar 31, 2023Mar 31, 2022Mar 31, 2021Mar 31, 2020Mar 31, 2019
Profit or loss [abstract]
Revenue
Cost of sales
Selling, general and administrative expenses
Research and development expenses
Amortization and impairment losses on intangible assets associated with products
Other operating income
Other operating expenses
Operating profit
Finance income
Finance expenses
Share of profit (loss) of investments accounted for using the equity method
Profit (loss) before tax
Income tax (expenses) benefit
Net profit (loss) for the year
Attributable to:
Owners of the Company
Non-controlling interests
Net profit (loss) for the year
Earnings per share (JPY)
Basic earnings (loss) per share (in JPY per share)
Diluted earnings (loss) per share (in JPY per share)